[HTML][HTML] Neuromodulatory treatments for psychiatric disease: a comprehensive survey of the clinical trial landscape
Background Numerous neuromodulatory therapies are currently under investigation or in
clinical use for the treatment of psychiatric conditions. Objective/hypothesis We sought to …
clinical use for the treatment of psychiatric conditions. Objective/hypothesis We sought to …
Transcranial magnetic stimulation for the treatment of anxiety disorder
Anxiety is currently one of the main mood changes and can impair the quality of life of the
individual when associated with other neurological or psychiatric disorders …
individual when associated with other neurological or psychiatric disorders …
Efficacy and tolerability of Brain Stimulation interventions in Borderline Personality Disorder: state of the art and future perspectives–a systematic review
Abstract Treating Borderline Personality Disorder (BPD) is a major challenge for
psychiatrists. As Brain Stimulation represents an alternative approach to treat psychiatric …
psychiatrists. As Brain Stimulation represents an alternative approach to treat psychiatric …
Impulsivity and its therapeutic management in borderline personality disorder: a systematic review
No treatment has been approved and recognized as effective in borderline personality
disorder (BPD). Impulsivity is a key dimension because it is a predictor of remission but also …
disorder (BPD). Impulsivity is a key dimension because it is a predictor of remission but also …
Repetitive transcranial magnetic stimulation in patients with borderline personality disorder: a systematic review
The literature on the application of repetitive transcranial magnetic stimulation (rTMS) in
Borderline Personality Disorder (BPD) is unclear, even though its neuromodulatory effects …
Borderline Personality Disorder (BPD) is unclear, even though its neuromodulatory effects …
Efficacy of noninvasive brain stimulation on borderline personality disorder core symptoms: a systematic review
S Chiappini, E Picutti, MC Alessi, F Di Carlo… - Journal of Personality …, 2022 - Guilford Press
Although psychotherapy is the first-line treatment of borderline personality disorder (BPD),
psychopharmacological agents have not been approved yet. Modulating brain functions with …
psychopharmacological agents have not been approved yet. Modulating brain functions with …
Change in core symptoms of borderline personality disorder by tDCS: A pilot study
Borderline personality disorder (BPD) recognizes several psychopathological dimensions
related to prefrontal cortex impairments. Transcranial Direct Current Stimulation (tDCS) …
related to prefrontal cortex impairments. Transcranial Direct Current Stimulation (tDCS) …
[HTML][HTML] Improvement in borderline personality disorder symptomatology after repetitive transcranial magnetic stimulation of the dorsomedial prefrontal cortex …
AR Calderón-Moctezuma, JV Reyes-López… - Brazilian Journal of …, 2020 - SciELO Brasil
Objective: Current treatment for borderline personality disorder (BPD) involves
psychological and pharmacological interventions. However, neuromodulation techniques …
psychological and pharmacological interventions. However, neuromodulation techniques …
Borderline personality traits do not influence response to TMS
HB Ward, A Yip, R Siddiqui, OG Morales… - Journal of Affective …, 2021 - Elsevier
Comorbid personality disorders are common in patients with major depressive disorder
(MDD). Individuals with comorbid borderline personality disorder (BPD) may be less …
(MDD). Individuals with comorbid borderline personality disorder (BPD) may be less …
A feasibility trial of conjoint magnetic seizure therapy and dialectical behavior therapy for suicidal patients with borderline personality disorder and treatment-resistant …
Non-invasive brain stimulation interventions for treating suicidal ideation in individuals with
treatment-resistant depression offer the potential for new therapeutic options for patients with …
treatment-resistant depression offer the potential for new therapeutic options for patients with …